News Details
Category : IPO
Headline : Mankind Pharma Ltd. debuts with 20.37% premium at Rs 1,300.00
Date: 09/05/2023 10:40
Mankind Pharma Ltd. makes a strong debut on the bourses with scrip got listed at Rs 1,300.00 on the Bombay Stock Exchange, a 20.37 per cent premium to its issue price of Rs 1,080.00. On the National Stock Exchange, the stock was listed at Rs 1,300.00.

The company, which raised 4.01 Cr from initial public offering, was subscribed 0 times, receiving bids for 0 lakhs shares against the total issue size of 400.59 lakhs shares.

The company, listed under B Group Securities post its IPO, opened for subscription from Apr 25 to Apr 27.

Following a strong opening, the scrip touched an intraday high of Rs [BSEHighPrice] and a low of Rs [NSEHighPrice], before closing the session [UpDown] by [ChangePer] per cent to its listing price at Rs [ClosingPriceBSE] on the BSE.

The company anticipates using the proceeds of the issue for .

Axis Capital Ltd.,JP Morgan India Private Limited.,Jefferies India Pvt. Ltd.,Kotak Mahindra Capital Company Limited,IIFL Securities Limited as lead managers & KFIN Technologies Pvt. Ltd. is the registrar, to the issue.

Meanwhile, the broader benchmark BSE Sensex closed trade at 61,764.25, up 709.96 points, or 1.16 per cent.